MENU
CANF
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Can-Fite BioPharma (CANF) Ownership - Who owns Can-Fite BioPharma?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
26 Ben Gurion Street
Phone
+972 39241114
Employees
5
Web
http://www.canfite.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
9.17M
P/E Ratio
N/A
Total Cash
4.73M
Projected Growth
N/A
Total Debt
57K
Revenue
667K
Risk (Beta)
1.12
Dividend Yield
N/A
Total Cash/Share
0.78
Total Debt/Equity
N/A
Revenue/Share
0.13 USD as % of share price
Fundamentals
CANF
Capitalization
9.17M
P/E Ratio
N/A
Risk (Beta)
1.12
Dividend Yield
N/A
Total Cash
4.73M
Total Cash/Share
0.78
Total Debt
57K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.13%
Revenue
667K
ROE
N/A
Book Value
2.48M
P/B Ratio
3.49
Cash Flow
N/A
Earnings
-2.6
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
2.93
Current Revenue Per Employee
31000.00
Dividends Per Share - Security
N/A
EBITDA
-7.79M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-86.95
Shares Held By Institutions
1.79M
Shares Outstanding - Current
6.1M
Total Liabilities
3.44M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-35.455
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biopharmaceuticals for treatment of autoimmune diseases and cancers
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
26 Ben Gurion Street
Phone
+972 39241114
Employees
5
Web
http://www.canfite.com